- Home
- / Lipella Pharmaceuticals
Lipella Pharmaceuticals
Stock Price
$0.4
2024-10-29
Market Capitalization
$4 M
2024-10-29
Revenue
$536.4 K
FY, 2024
Lipella Pharmaceuticals Summary
Company Summary
- Overview
- Lipella Pharmaceuticals is a biotechnology company that develops treatments for serious diseases. It focuses on developing drug delivery technologies for bladder, urethra, oral cavity, esophagus, and colon disease treatment.
- Type
- Public
- Status
- Active
- Founded
- 2005
- HQ
- Pittsburgh, PA, US | view all locations
- Website
- https://lipella.com/
- Cybersecurity rating
Table of Contents
Key People
Michael Chancellor, Chief Medical Officer, Director
Douglas Johnston, Chief Financial Officer
Michele Gruber, Director of Operations
LocationsView all
1 location detected
Pittsburgh, PA HQ
United States
7800 Susquehanna St, Suite 505
Lipella Pharmaceuticals Financials
Summary Financials
- Net income (Q3, 2025)
- ($1.3M)
- Cash (Q3, 2025)
- $1.9M
- EBIT (Q3, 2025)
- ($1.3M)
- Enterprise value
- $2.4M